Immune dysfunction linked to persistent post-COVID symptomsIn a study led by researchers from Amsterdam UMC and UMC Utrecht, antibodies from patients with post-COVID were found to trigger long-lasting symptoms in mice. The research builds on data and biological samples from the NMCB cohort, one of the cohorts within Amsterdam Cohort Hub.
Wilma Van de Berg looks at Parkinson’s disease through different lensesWith her expertise in neuropathology, biobanking, and high-end microscopy analysis of human brain tissue, Wilma Van de Berg aims to improve early diagnosis and develop disease-modifying therapies for Parkinson’s disease. In her inaugural lecture on December 18, 2025, Professor Wilma Van de Berg will bring together different perspectives on disease progression as the newly appointed Professor Cellular Neurodegeneration, Parkinson’s disease at the Vrije Universiteit Amsterdam.
PAIS IMPACT | The Dutch Lyme Disease Expertise Center: From Research to Real-World Impact At the Amsterdam institute for Immunology and Infectious diseases (AI&I), we focus our research and outreach on three key themes: Post-Acute Infection Syndrome (PAIS), Immunomonitoring, and Vaccination. Each quarter, we highlight one of these areas through a dedicated series of articles. This quarter (Q4 2025), our spotlight is on PAIS. In this article, we focus on the impact of PAIS research, with special attention to the work of the Dutch Lyme Disease Expertise Center (NLe).
